Cargando…

Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study

BACKGROUND: The introduction of highly active retroviral therapy has dramatically reduced mortality and improved survival among HIV patients. However, there is a possible risk of comorbid complications such as hypertension. Little evidence is available regarding the incidence of hypertension among H...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulugeta, Henok, Afenigus, Abebe Dilie, Haile, Dessalegn, Amha, Haile, Kassa, Getachew Mullu, Wubetu, Muluken, Abebaw, Ermias, Jara, Dube
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435532/
https://www.ncbi.nlm.nih.gov/pubmed/34526825
http://dx.doi.org/10.2147/HIV.S329838
_version_ 1783751814292701184
author Mulugeta, Henok
Afenigus, Abebe Dilie
Haile, Dessalegn
Amha, Haile
Kassa, Getachew Mullu
Wubetu, Muluken
Abebaw, Ermias
Jara, Dube
author_facet Mulugeta, Henok
Afenigus, Abebe Dilie
Haile, Dessalegn
Amha, Haile
Kassa, Getachew Mullu
Wubetu, Muluken
Abebaw, Ermias
Jara, Dube
author_sort Mulugeta, Henok
collection PubMed
description BACKGROUND: The introduction of highly active retroviral therapy has dramatically reduced mortality and improved survival among HIV patients. However, there is a possible risk of comorbid complications such as hypertension. Little evidence is available regarding the incidence of hypertension among HIV patients receiving anti-retroviral therapy in Ethiopia. PURPOSE: To assess the incidence and predictors of hypertension among HIV positive patients receiving ART at Public Health Facilities, Northwest Ethiopia. PATIENTS AND METHODS: A one-year prospective follow-up study was conducted among a cohort of 302 new adult individuals initiating on a standard anti-retroviral therapy regimen with a median (IQR) age of 35 years (IQR=30–41). A pretested data extraction checklist was used to extract baseline patient records. The collected data were entered into Epi-Data version 3.1 and exported to STATA version 14 for analysis. The incidence rate was calculated, and a Kaplan–Meier survival curve was used to estimate the survival probabilities of developing hypertension. Cox proportional hazards model was fitted to identify the predictors of hypertension. RESULTS: About 40 (13.25) new hypertensive cases were observed during the follow-up period, and the remaining 262 (86.75%) were censored. The overall incidence rate of hypertension was 16.35 per 1000 person-month with 2447 patient-month observations. Male sex (AHR = 2.45, 95% CI: 1.02, 6.14), old age (AHR = 2.83, 95% CI: 1.08, 7.45), high BMI (AHR = 6.54, 95% CI: 2.03, 21.13), diabetic comorbidity (AHR = 2.36, 95% CI: 1.07, 5.22), and patients who were on Zidovudine (AZT)-based ART regimen (AHR =3.47, 95% CI: 1.10, 10.94) were significant predictors for the development of hypertension. CONCLUSION: The findings of this study revealed that incident hypertension is a common problem among HIV patients receiving ART. Routine monitoring of blood pressure and screening and treating high blood pressure should be an integral part of follow-up for HIV patients in ART clinics.
format Online
Article
Text
id pubmed-8435532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84355322021-09-14 Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study Mulugeta, Henok Afenigus, Abebe Dilie Haile, Dessalegn Amha, Haile Kassa, Getachew Mullu Wubetu, Muluken Abebaw, Ermias Jara, Dube HIV AIDS (Auckl) Original Research BACKGROUND: The introduction of highly active retroviral therapy has dramatically reduced mortality and improved survival among HIV patients. However, there is a possible risk of comorbid complications such as hypertension. Little evidence is available regarding the incidence of hypertension among HIV patients receiving anti-retroviral therapy in Ethiopia. PURPOSE: To assess the incidence and predictors of hypertension among HIV positive patients receiving ART at Public Health Facilities, Northwest Ethiopia. PATIENTS AND METHODS: A one-year prospective follow-up study was conducted among a cohort of 302 new adult individuals initiating on a standard anti-retroviral therapy regimen with a median (IQR) age of 35 years (IQR=30–41). A pretested data extraction checklist was used to extract baseline patient records. The collected data were entered into Epi-Data version 3.1 and exported to STATA version 14 for analysis. The incidence rate was calculated, and a Kaplan–Meier survival curve was used to estimate the survival probabilities of developing hypertension. Cox proportional hazards model was fitted to identify the predictors of hypertension. RESULTS: About 40 (13.25) new hypertensive cases were observed during the follow-up period, and the remaining 262 (86.75%) were censored. The overall incidence rate of hypertension was 16.35 per 1000 person-month with 2447 patient-month observations. Male sex (AHR = 2.45, 95% CI: 1.02, 6.14), old age (AHR = 2.83, 95% CI: 1.08, 7.45), high BMI (AHR = 6.54, 95% CI: 2.03, 21.13), diabetic comorbidity (AHR = 2.36, 95% CI: 1.07, 5.22), and patients who were on Zidovudine (AZT)-based ART regimen (AHR =3.47, 95% CI: 1.10, 10.94) were significant predictors for the development of hypertension. CONCLUSION: The findings of this study revealed that incident hypertension is a common problem among HIV patients receiving ART. Routine monitoring of blood pressure and screening and treating high blood pressure should be an integral part of follow-up for HIV patients in ART clinics. Dove 2021-09-07 /pmc/articles/PMC8435532/ /pubmed/34526825 http://dx.doi.org/10.2147/HIV.S329838 Text en © 2021 Mulugeta et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mulugeta, Henok
Afenigus, Abebe Dilie
Haile, Dessalegn
Amha, Haile
Kassa, Getachew Mullu
Wubetu, Muluken
Abebaw, Ermias
Jara, Dube
Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title_full Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title_fullStr Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title_full_unstemmed Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title_short Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study
title_sort incidence and predictors of hypertension among hiv patients receiving art at public health facilities, northwest ethiopia: a one-year multicenter prospective follow-up study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435532/
https://www.ncbi.nlm.nih.gov/pubmed/34526825
http://dx.doi.org/10.2147/HIV.S329838
work_keys_str_mv AT mulugetahenok incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT afenigusabebedilie incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT hailedessalegn incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT amhahaile incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT kassagetachewmullu incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT wubetumuluken incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT abebawermias incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy
AT jaradube incidenceandpredictorsofhypertensionamonghivpatientsreceivingartatpublichealthfacilitiesnorthwestethiopiaaoneyearmulticenterprospectivefollowupstudy